A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

Januar 2025A team of Jülich scientists used a special RNA molecule to specifically attack and destroy glioblastoma cancer cells. The selectively ...

CVGBM, an investigational cancer vaccine, induced T-cell responses in patients with MGMT-unmethylated glioblastoma.

Researchers have identified a unique stem cell in the young brain capable of maturing into multiple cell types, potentially explaining the origins of autism and glioblastoma.

The discovery of a new type of stem cell in the brain could usher in better treatments for the deadliest brain tumor.

UCSF scientists have discovered a stem cell in the young brain that's capable of forming the cells found in tumors. The ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a ...